Na channel blockers
Across
- 7. : Has additional beta-blocker properties; avoid in asthma
- 9. : Contraindicated in structural heart disease post-MI
- 12. : Causes bone marrow suppression and hyponatremia
- 14. : Alternate name for phenytoin; narrow therapeutic index
- 15. : Used for ocular anesthesia; corneal toxicity if overused
- 16. : May cause kidney stones and weight loss
- 19. : May induce drug-induced lupus erythematosus
- 20. : Removed from market; pro-arrhythmic post-MI
- 22. : Can prolong PR interval; monitor ECG
- 23. : Similar to carbamazepine with lower hepatic interaction
- 24. : Also used for digoxin-induced arrhythmias and epilepsy
Down
- 1. : Risk of Stevens-Johnson syndrome with rapid titration
- 2. : Avoid in heart failure due to negative inotropic effect
- 3. : Ester-type local anesthetic; risk of PABA allergy
- 4. : Shortens QT; used in Lennox-Gastaut syndrome
- 5. : Used IV to treat post-MI ventricular arrhythmias
- 6. : Late sodium current blocker that prolongs QT
- 8. : Oral lidocaine-like drug for chronic ventricular arrhythmias
- 10. : Risk of hyponatremia; related to oxcarbazepine
- 11. : Withdrawn after CAST trial due to increased mortality
- 13. : Used in Brugada syndrome diagnosis; high arrhythmia risk
- 17. : Can cause QT prolongation leading to Torsades de Pointes
- 18. : Used for migraine prophylaxis and can impair cognition
- 21. : ENT anesthetic with vasoconstrictive and cardiotoxic effects